Welch Capital Partners LLC NY Makes New Investment in P3 Health Partners Inc. (NASDAQ:PIII)

Welch Capital Partners LLC NY acquired a new stake in shares of P3 Health Partners Inc. (NASDAQ:PIII) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 30,000 shares of the company’s stock, valued at approximately $42,000. P3 Health Partners accounts for approximately 0.0% of Welch Capital Partners LLC NY’s holdings, making the stock its 20th largest holding.

Several other institutional investors also recently made changes to their positions in PIII. Emfo LLC increased its position in P3 Health Partners by 7.9% during the 3rd quarter. Emfo LLC now owns 1,004,147 shares of the company’s stock worth $1,476,000 after purchasing an additional 73,725 shares in the last quarter. Principal Financial Group Inc. grew its stake in P3 Health Partners by 13.3% during the third quarter. Principal Financial Group Inc. now owns 80,055 shares of the company’s stock worth $118,000 after buying an additional 9,400 shares during the period. PNC Financial Services Group Inc. purchased a new stake in P3 Health Partners during the third quarter worth approximately $101,000. Finally, SlateStone Wealth LLC acquired a new stake in shares of P3 Health Partners in the fourth quarter worth $40,000. 7.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. BTIG Research lowered shares of P3 Health Partners from a “buy” rating to a “neutral” rating in a report on Monday, April 1st. Lake Street Capital reduced their price objective on P3 Health Partners from $9.00 to $4.50 and set a “buy” rating on the stock in a research note on Thursday, March 14th. Finally, William Blair reiterated an “outperform” rating on shares of P3 Health Partners in a research note on Monday, April 1st.

P3 Health Partners Stock Up 14.7 %

Shares of NASDAQ PIII traded up $0.07 during trading on Tuesday, reaching $0.54. 249,229 shares of the stock were exchanged, compared to its average volume of 377,223. The company has a market capitalization of $169.70 million, a price-to-earnings ratio of -0.83 and a beta of 1.04. The business’s 50-day moving average price is $0.84 and its 200 day moving average price is $1.11. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.76. P3 Health Partners Inc. has a twelve month low of $0.44 and a twelve month high of $5.56.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Thursday, March 28th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.03). The firm had revenue of $346.86 million during the quarter, compared to analyst estimates of $309.80 million. P3 Health Partners had a negative return on equity of 120.85% and a negative net margin of 4.56%. As a group, equities analysts forecast that P3 Health Partners Inc. will post -0.56 EPS for the current fiscal year.

P3 Health Partners Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.